Peptide Pool Concepts from Discovery to the Clinic
Published on 01/06/2021
Recent virus outbreaks related to COVID-19, ZIKA, and EBOLA; therapeutic advances in treating TB, HIV, and HPV infections; and new cancer immunotherapies have led to increased interest in peptide tools. JPT has developed hundreds of innovative peptide products for addressing both humoral and cellular immunity. Have you considered how they might help facilitating the development of your vaccines and immunotherapies!
We are happy to announce the expansion of our PepMix Peptide Pool product line to enhance development of rapid antigen discovery efforts and for clinical trial therapies and immune monitoring assays.
Please contact us to discuss the benefits of using tailored, ISO 9001:2015 – regulated peptide products:
- SpotMix™ Antigen Discovery Pools for fast vaccine target identification & deep antigen profiling in cancer, infection, autoimmunity & more
- PepMix™ Purified Peptide Pools (catalog & customized) for immune monitoring, T cell expansion & methods development
- Clinical PepMix™ Peptide Pools for development of cell therapy, clinical trial immune monitoring & immune diagnostics
- Matrix Pools for rapid epitope discovery with minimal sample consumption
- Rapid assembly of multiple, small scale, low cost antigen peptide pools
- Guaranteed peptide identity, pool content and purity level
- Regulated manufacturing for clinical applications
- Scaled peptide pools from micrograms to multi-grams
- ADCF policies, line clearance, and complete batch documentation available
As always, we encourage your feedback. Let us discuss your project!